Blood component transfusion in primary coronary artery bypass surgery in Kuwait

Affiliations

01 March 2005

-

doi: 10.1159/000083916


Abstract

Objective: The aims of this study were to determine the rate of blood product transfusion, associated perioperative factors and cost of such blood product transfusion in primary coronary artery bypass surgery (CABG).

Subjects and methods: The medical records of 159 consecutive primary CABG patients (142 male, 17 female) from January 1, 2003 to June 30, 2003 at Chest Diseases Hospital, Kuwait, were reviewed. Urgent and emergency cases were included.

Results: The mean age of the patients was 57.2 (range 36-77 years). Overall, 128 (80.5%) patients received blood product transfusion during primary CABG: 113 (70.5%) packed red blood cells (RBC), 54 (33.9%) fresh frozen plasma, and 13 (8%) platelets. Overall, 23 patients (12.6%) received more than two RBC transfusions intraoperatively. Significant factors for intraoperative RBC transfusion were: age >60 years, female gender, preoperative hemoglobin <12 g/dl, and 3 or more coronary bypass grafts constructed. One hundred and fifty-nine patients consumed 342 units of RBC at an average of 2.1 RBC units per patient. The cost per patient was 80 Kuwaiti dinar (KD; USD 240).

Conclusion: The findings indicate a high rate of blood component transfusion in primary CABG patients in Kuwait that could expose the patients to the possible adverse effects, and such transfusions have high economic impact.


Similar articles

Predictors of packed red cell transfusion after isolated primary coronary artery bypass grafting--the experience of a single cardiac center: a prospective observational study.

Elmistekawy EM, Errett L, Fawzy HF.J Cardiothorac Surg. 2009 May 7;4:20. doi: 10.1186/1749-8090-4-20.PMID: 19422707 Free PMC article.

Impact of major bleeding and blood transfusions after cardiac surgery: analysis from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial.

Stone GW, Clayton TC, Mehran R, Dangas G, Parise H, Fahy M, Pocock SJ.Am Heart J. 2012 Mar;163(3):522-9. doi: 10.1016/j.ahj.2011.11.016.PMID: 22424026 Clinical Trial.

Effects of a waiting period after clopidogrel treatment before performing coronary artery bypass grafting.

Reichert MG, Robinson AH, Travis JA, Hammon JW, Kon ND, Kincaid EH.Pharmacotherapy. 2008 Feb;28(2):151-5. doi: 10.1592/phco.28.2.151.PMID: 18225962

Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery.

Kuduvalli M, Oo AY, Newall N, Grayson AD, Jackson M, Desmond MJ, Fabri BM, Rashid A.Eur J Cardiothorac Surg. 2005 Apr;27(4):592-8. doi: 10.1016/j.ejcts.2005.01.030.PMID: 15784356

Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting.

Lindvall G, Sartipy U, van der Linden J.Ann Thorac Surg. 2005 Sep;80(3):922-7. doi: 10.1016/j.athoracsur.2005.03.079.PMID: 16122456 Clinical Trial.


Cited by

The impact of blood use on patients undergoing coronary artery bypass surgery: a prospective study.

Lako A, Bilali S, Memishaj S, Daka A, Dedej T, Nurka T, Bilali V, Gjylameti V.G Chir. 2014 Jan-Feb;35(1-2):20-6.PMID: 24690337 Free PMC article.

Predictors of packed red cell transfusion after isolated primary coronary artery bypass grafting--the experience of a single cardiac center: a prospective observational study.

Elmistekawy EM, Errett L, Fawzy HF.J Cardiothorac Surg. 2009 May 7;4:20. doi: 10.1186/1749-8090-4-20.PMID: 19422707 Free PMC article.


References

https://pubmed.ncbi.nlm.nih.gov/